Abacus Health Products crafts potent CBD-infused topical solutions with FDA-approved analgesics for effective pain relief. Founded in 2015, the company creates, markets, and sells CBDCLINIC™ and CBDMEDIC™, the first family of FDA-registered over-the-counter topical pain relief products infused with cannabidiol (CBD), a medicinal and non-psychoactive extract from cannabis. These offerings feature a blend of CBD and terpenes combined with various concentrations of FDA-approved analgesics designed to alleviate mild to severe pain symptoms. The last investment made in the company was a $34.50M Post-IPO Equity investment on 08 May 2019. The investors involved in this last investment round have not been disclosed.
General Information
BounceWatch is an independent company data service, not affiliated with Abacus Health Products. To contact Abacus Health Products, visit abacushp.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Biotechnology
About Abacus Health Products
Taxonomy: CBD-infused, topical solutions, pain relief, FDA-approved, cannabidiol, CBDCLINIC, CBDMEDIC, over-the-counter, terpenes, analgesics, cannabis extract, medicinal, non-psychoactive, marketing
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $34.50M | - |
|
08 May 2019 |
Abacus Health Products Alternatives & Competitors
OTC Registered Topical Pain Relief Blended With Hemp Extract
FAQ About Abacus Health Products
Source: BounceWatch company record for Abacus Health Products, https://bouncewatch.com/company/abacus-health-products, updated 27 October 2024. When citing, please name BounceWatch and link this page.